Invention Grant
- Patent Title: Antibodies against 4G7-derived chimeric antigen receptors
-
Application No.: US16851691Application Date: 2020-04-17
-
Publication No.: US11732041B2Publication Date: 2023-08-22
- Inventor: Thomas Charles Pertel , Barbra Johnson Sasu , Tao Sai
- Applicant: ALLOGENE THERAPEUTICS, INC.
- Applicant Address: US CA South San Francisco
- Assignee: ALLOGENE THERAPEUTICS, INC.
- Current Assignee: ALLOGENE THERAPEUTICS, INC.
- Current Assignee Address: US CA South San Francisco
- Agency: Allogene Therapeutics, Inc.
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K16/42 ; A61K35/17
Abstract:
Provided herein are isolated antibodies that specifically bind anti-CD19 chimeric antigen receptors (CARs) derived from a 4G7 scFv. Also provided are methods of making and using these isolated antibodies.
Public/Granted literature
- US20200331998A1 ANTIBODIES AGAINST 4G7-DERIVED CHIMERIC ANTIGEN RECEPTORS Public/Granted day:2020-10-22
Information query
